欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/2192/001
药品名称Levetiracetam concentrate for solution for injection/ infusion 100 mg/ml
活性成分
    • Levetiracetam 100.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Sandoz B.V. Hospitaaldreef 29 1315 RC Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Levetiracetam Sandoz infuus 100 mg/ml, concentraat voor oplossing voor infusie
互认成员国 - 产品名称
    • Belgium (BE)
    • Austria (AT)
      Levetiracetam Sandoz 100 mg/ml - Konzentrat zur Herstellung einer Infusionslösung
    • Spain (ES)
    • Finland (FI)
    • United Kingdom (Northern Ireland) (XI)
许可日期2011/09/12
最近更新日期2025/01/07
药物ATC编码
    • N03AX14 levetiracetam
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase